Ideology Trumps Science in Ongoing FDA Stall of Plan B

Ideology Trumps Science in Ongoing FDA Stall of Plan B

After more than a year of waiting for over-the-counter access to emergency contraception, also known as the morning-after pill, it is again before the FDA, which has twice delayed a decision on the product. The FDA delayed its decision on Plan B, the commercial name of emergency contraception, osten...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:National NOW Times 2005-01, Vol.37 (3), p.1
1. Verfasser: Lamarre, Meaghan
Format: Artikel
Sprache:eng
Schlagworte:
Birth control
FDA approval
Nonprescription drugs
Womens rights movements
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:After more than a year of waiting for over-the-counter access to emergency contraception, also known as the morning-after pill, it is again before the FDA, which has twice delayed a decision on the product. The FDA delayed its decision on Plan B, the commercial name of emergency contraception, ostensibly to receive public comments on and study the practical and regulatory implications of allowing OTC access only to women aged 17 and over while requiring a prescription for younger women.
ISSN:0149-4740